SRSF6 overexpression increased migration and invasion in breast cancer cells (Park et al., 2019) and induced epithelial–mesenchymal transition (EMT) in colorectal cancer cells (Kong et al., 2016). Here, SRSF6 is linked to colorectal cancer.